MedTrace Logo

Effects of Heart Rate Oscillations During Meditation on Plasma Biomarkers of Alzheimer's Disease

NCT06210035 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 94

Last updated 2026-01-05

Study results available
· View outcomes & findings →

Summary

In the current study, we will examine how two types of concentration meditation practices affect plasma biomarkers of Alzheimer's Disease (AD). We will also examine the effects of the two types of meditation practices on emotional well-being and episodic memory. Healthy adults aged 18-35 who meet all eligibility criteria will be invited to this study. Participants will be asked to engage in one week of daily meditation practice or no-intervention control task at home. They will also be asked to visit the lab twice, once before and once after the intervention, to provide blood samples to assess plasma biomarkers of AD and to complete emotion questionnaires and a memory test.

Conditions

  • Alzheimer Disease

Interventions

BEHAVIORAL

Belly-focus meditation

Participants will engage in concentration meditation for 40 minutes every day for a week. They will focus on the sensations around the belly.

BEHAVIORAL

Belly-focus meditation with slow breathing

Participants will engage in concentration meditation and slow breathing for 40 minutes every day for a week. They will focus on the sensations around the belly while breathing slowly.

Sponsors & Collaborators

  • University of California, Irvine

    collaborator OTHER

  • University of Southern California

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
35 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-01-29
Primary Completion
2024-05-03
Completion
2024-05-03

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06210035 on ClinicalTrials.gov